Skip to main content
Glama

Gnews

by io.github.pipeworx-io

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already indicate readOnlyHint=true, openWorldHint=true, idempotentHint=true, destructiveHint=false. The description adds details: for companies, it pulls latest 10-K data from SEC EDGAR/XBRL with proper off-calendar handling; for drugs, FAERS adverse-event counts. It also mentions sorted results and citation URIs.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Description is thorough but slightly long. However, it is well-structured with usage examples front-loaded and each sentence providing necessary information. Minor redundancy could be trimmed, but overall clear.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the annotations and input schema, the description fully explains the tool's capabilities: input requirements, data sources, handling of fiscal years, output format (paired data + citation URIs). No output schema exists, but the description sufficiently covers return values.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, but description adds meaning beyond enum values: 'company' yields revenue+net income+cash+debt; 'drug' yields FAERS counts, FDA approvals, trial counts. It explains values format (tickers/CIKs for companies, names for drugs) and limits (2-5 items).

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool performs side-by-side comparison of 2-5 companies or drugs in one parallel call, with specific verb phrases like 'compare', 'X vs Y', 'rank these companies'. It distinguishes from sequential single-pack lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly states 'ALWAYS PREFER over sequential single-pack lookups when comparing entities.' It explains what each type (company/drug) returns, providing clear context for when to use. Does not specify when not to use, but alternatives are implicit.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Gnews toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation4/5

Most tools have distinct, well-described purposes, but there is some overlap, especially among prediction market tools (bet_research, polymarket_arbitrage, etc.) and between ask_pipeworx and ask_pipeworx_grounded. Agents might occasionally select the wrong tool without careful reading.

Naming Consistency3/5

Tool names follow a mix of snake_case and camelCase (e.g., ai_visibility_check vs discover_tools). Some names are descriptive but inconsistent in style (subscribe, unsubscribe, list_subscriptions). Pattern is not uniform.

Tool Count3/5

With 32 tools, the server covers many domains (news, financials, prediction markets, entity resolution, memory). While each tool has a justification, the count feels heavy for a single server, and some tools could be consolidated.

Completeness3/5

The tool set spans a wide range of data sources and operations, but there are notable gaps. For news, only search and top headlines exist without advanced filtering. Prediction markets lack order placement tools. The broad scope means depth is sacrificed in some areas.

Resources